Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GNE-490 is an inhibitor of PI3K (IC50s = 3.5, 25, 5.2, and 15 nM for PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ, respectively).1 It is selective for PI3K over mTOR (IC50 = 740 nM) and a panel of 142 kinases at 1 µM. GNE-490 (0.4 µM) reduces cell migration by, the number of vessel outgrowths from, and induces apoptosis in, human umbilical vein endothelial cells (HUVECs).2 It increases the length of circadian rhythms in zebrafish larvae.3 GNE-490 (30 mg/kg) decreases vascularization and tumor growth in a PC3 prostate cancer mouse xenograft model.2
WARNING This product is not for human or veterinary use.
1. Discovery of (thienopyrimidin-
2. Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response. Neoplasia 15(7), 694-711 (2013).
3. Identification of pathways that regulate circadian rhythms using a larval zebrafish small molecule screen. Sci. Rep. 9(1), 12405 (2019).